Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H18O24P6 |
Molecular Weight | 660.0353 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
InChI
InChIKey=IMQLKJBTEOYOSI-GPIVLXJGSA-N
InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/t1-,2-,3-,4+,5-,6-
Molecular Formula | C6H18O24P6 |
Molecular Weight | 660.0353 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8777015https://www.ncbi.nlm.nih.gov/pubmed/27272247Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16401188 | https://www.ncbi.nlm.nih.gov/pubmed/28233043 | https://www.ncbi.nlm.nih.gov/pubmed/26859648 | https://www.ncbi.nlm.nih.gov/pubmed/20127021
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8777015https://www.ncbi.nlm.nih.gov/pubmed/27272247
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16401188 | https://www.ncbi.nlm.nih.gov/pubmed/28233043 | https://www.ncbi.nlm.nih.gov/pubmed/26859648 | https://www.ncbi.nlm.nih.gov/pubmed/20127021
Phytate Sodium is a complex sodium salt of the corn-derived plant component Phytic Acid , that used as a chelating agent in all types of cosmetic products, including soaps, shampoos, balms and leave-on products for the face or body. Phytate Sodium is a biodegradable product and appears in the form of a dark-coloured liquid, is soluble in water and has a characteristic odour. It can be used in all types of cosmetic products, including soaps, shampoos, balms and leave-on products for the face or body. In vivo and in vitro experiments have demonstrated striking anticancer (preventive as well as therapeutic) effects of phytic acid. Research shows anti-carcinogenic effects, albeit to a lesser extent and it acts in inhibiting cancer. In addition to reduction in cell proliferation, phytic acid increases differentiation of malignant cells often resulting in reversion to the normal phenotype. Phytates participation in important intracellular biochemical pathways, normal physiological presence in human cells, tissues, plasma, urine, etc., the levels of which fluctuate with intake, epidemiological correlates of phytate deficiency with disease and reversal of those conditions by adequate intake, and safety – all strongly suggest for phytates inclusion as an essential nutrient, perhaps a vitamin. Phytic acid, mostly as Phytate Sodium or other phytates, is found within the hulls of nuts, seeds, and grains. No detectable phytate (less than 0.02 % of wet weight) was observed in vegetables such as scallion and cabbage leaves or in fruits such as apples, oranges, bananas, or pears. In-home food preparation techniques can break down the phytic acid in all of these foods. Simply cooking the food will reduce the phytic acid to some degree. More effective methods are soaking in an acid medium, sprouting and lactic acid fermentation such as in sourdough and pickling.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0034440 |
|||
Target ID: Metals (Iron, Zinc) |
|||
Target ID: AP2 complex |
|||
Target ID: CHEMBL2363056 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28233043 |
|||
Target ID: CHEMBL2364030 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28233043 |
|||
Target ID: GO:0055065 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28233043 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Sources: DOI: 10.1046/j.1365-2621.2002.00620.x |
Preventing | Unknown Approved UseUnknown |
||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Sources: http://www.nutrientsreview.com/phytonutrients/phytic-acid-inositol-hexaphosphate.html https://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=grasnotices&id=381 https://naturellecosmetics.com/iblog/reasons-for-phytic-acid-use-in-natural-cosmetics http://www.biosiltech.com/pdf/Phytic%20Acid%20Extreme%20-%20Data%20Sheet%202017.pdf http://www.biosiltech.com/pdf/new_formula_sheets/Phytic%20Acid%20Resurfacing%20Toner%20PS1-301.pdf |
Primary | Unknown Approved UseUnknown |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
0.12 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11673644/ |
1400 mg single, oral dose: 1400 mg route of administration: Oral experiment type: SINGLE co-administered: |
FYTIC ACID plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
0.52 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11673644/ |
1400 mg single, oral dose: 1400 mg route of administration: Oral experiment type: SINGLE co-administered: |
FYTIC ACID plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11673644/ |
1400 mg single, oral dose: 1400 mg route of administration: Oral experiment type: SINGLE co-administered: |
FYTIC ACID plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/29282978/ Page: 26.0 |
likely |
PubMed
Title | Date | PubMed |
---|---|---|
Soybeans and cancer prevention: a complex food and a complex disease. | 2001 |
|
Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine. | 2001 |
|
Evaluation of selected food attributes of four advanced lines of ungerminated and germinated Nigerian cowpea (Vigna unguiculata (L.) Walp.). | 2001 |
|
Effect of processing on the nutrients and anti-nutrients of lima bean (Phaseolus lunatus L.) flour. | 2001 Apr |
|
Expression of D-myo-inositol-3-phosphate synthase in soybean. Implications for phytic acid biosynthesis. | 2001 Apr |
|
Distal ligand reactivity and quaternary structure studies of proximally detached hemoglobins. | 2001 Apr 3 |
|
A novel phytase with sequence similarity to purple acid phosphatases is expressed in cotyledons of germinating soybean seedlings. | 2001 Aug |
|
Pigs expressing salivary phytase produce low-phosphorus manure. | 2001 Aug |
|
Nutrient distribution and phenolic antioxidants in air-classified fractions of beach pea (Lathyrus maritimus L.). | 2001 Feb |
|
Chemical composition and nutritional characteristics of some hull less and hulled barley cultivars grown in India. | 2001 Feb |
|
Iron absorption from experimental infant formulas based on pea (Pisum sativum)-protein isolate: the effect of phytic acid and ascorbic acid. | 2001 Jan |
|
Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. | 2001 Jan |
|
Accessory spleen in the pelvis diagnosed by Tc-99m phytate scintigraphy. | 2001 Jun |
|
Effect of various domestic processing methods on antinutrients and in vitro protein and starch digestibility of two indigenous varieties of Indian tribal pulse, Mucuna pruriens Var. utilis. | 2001 Jun |
|
Determination of phytic acid by gas chromatography-mass spectroscopy: application to biological samples. | 2001 Jun 15 |
|
Development and sensory evaluation of soy milk based yoghurt. | 2001 Mar |
|
ATP production from adenine by a self-coupling enzymatic process: high-level accumulation under ammonium-limited conditions. | 2001 Mar |
|
Extracellular secretion of Aspergillus phytase from Arabidopsis roots enables plants to obtain phosphorus from phytate. | 2001 Mar |
|
Assessing the omnipotence of inositol hexakisphosphate. | 2001 Mar |
|
Inositol phosphates from barley low-phytate grain mutants analysed by metal-dye detection HPLC and NMR. | 2001 Mar 1 |
|
Direct observation of two distinct affinity conformations in the T state human deoxyhemoglobin. | 2001 Mar 9 |
|
Purification and properties of extracellular phytase from Bacillus sp. KHU-10. | 2001 May |
|
Dietary diversification/modification strategies to enhance micronutrient content and bioavailability of diets in developing countries. | 2001 May |
|
Reduction by phytate-reduced soybean beta-conglycinin of plasma triglyceride level of young and adult rats. | 2001 May |
|
Prolonged fermentation of whole wheat sourdough reduces phytate level and increases soluble magnesium. | 2001 May |
|
Transgenic mice expressing bacterial phytase as a model for phosphorus pollution control. | 2001 May |
|
Production, purification and properties of microbial phytases. | 2001 May |
|
Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis. | 2001 May 1 |
|
Phosphorylation of a synaptic vesicle-associated protein by an inositol hexakisphosphate-regulated protein kinase. | 2001 May 11 |
|
Utilisation of phytate phosphorus by rumen bacteria in a semi-continuous culture system (Rusitec) in lactating goats fed on different forage to concentrate ratios. | 2001 May-Jun |
|
Biotechnological development of effective phytases for mineral nutrition and environmental protection. | 2001 Nov |
|
Use of fungal phytase to improve breadmaking performance of whole wheat bread. | 2001 Nov |
|
The role of hepatobiliary scintigraphy in the follow-up of benign liver tumors secondary to oral contraceptive use. | 2001 Nov |
|
Ingestion of insoluble dietary fibre increased zinc and iron absorption and restored growth rate and zinc absorption suppressed by dietary phytate in rats. | 2001 Oct |
|
Identification and characterization of a novel inositol hexakisphosphate kinase. | 2001 Oct 19 |
|
Enzyme mechanism and catalytic property of beta propeller phytase. | 2001 Sep |
|
Calcium-binding capacities of different brans under simulated gastrointestinal pH conditions. In vitro study with (45)Ca. | 2001 Sep |
|
[In vitro availability of minerals in infant foods with different protein source]. | 2001 Sep-Oct |
|
Preparation of phytate-removed deamidated soybean globulins by ion exchangers and characterization of their calcium-binding ability. | 2002 Jan 2 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02081287
2,000 - 3,000 mg per day (in two doses)
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20930278
In MC65 cells, 48-72-hour treatment with phytic acid (100 uM) provided complete protection against amyloid precursor protein-C-terminal fragment-induced cytotoxicity by attenuating levels of increased intracellular calcium, hydrogen peroxide, superoxide, Aβ oligomers, and moderately upregulated the expression of autophagy (beclin-1) protein.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:11:07 GMT 2023
by
admin
on
Fri Dec 15 16:11:07 GMT 2023
|
Record UNII |
7IGF0S7R8I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C275
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
||
|
DSLD |
478 (Number of products:51)
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/12/1008
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
201-506-6
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
C87652
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
DTXSID40889331
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
83-86-3
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
7IGF0S7R8I
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
D010833
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
SUB07856MIG
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
100000084487
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
269896
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
1472
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
8302
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
17401
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
DB14981
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
PHYTIC ACID
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
7IGF0S7R8I
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
3465
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
381
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
1537910
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | |||
|
m8769
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL1233511
Created by
admin on Fri Dec 15 16:11:07 GMT 2023 , Edited by admin on Fri Dec 15 16:11:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |